Biotechnology Analysis & Statistics, November 2013 (p45)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: biotech, protein, biomedical, more »

1321-1350 of about 2 400 reports

Purchase Reports From Reputable Market Research Publishers

Changmao Biochemical Engineering Co., Ltd. - Financial and Strategic SWOT Analysis Review

Changmao Biochemical Engineering Co., Ltd. - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Changmao Biochemical Engineering Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Biotechnology
Tianjin TEDA Biomedical Co., Ltd. (8189) - Financial and Strategic SWOT Analysis Review

Tianjin TEDA Biomedical Co., Ltd. (8189) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Tianjin TEDA Biomedical Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biopharmaceutical
Sterling Biotech Limited (STERLINBIO) - Financial and Strategic SWOT Analysis Review

Sterling Biotech Limited (STERLINBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Sterling Biotech Limited provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biotechnology
John Daniel Holdings Limited (JDH) - Financial and Strategic SWOT Analysis Review

John Daniel Holdings Limited (JDH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary John Daniel Holdings Limited (JDHL) is a South African venture capital holding company. The company invests in companies, which are niche and strategic in nature in the healthcare, biotechnology ...

  • Industries : Biological Therapy
  • Countries : South Africa
Baotou Dongbao Biotech Co. Ltd. (300239) - Financial and Strategic SWOT Analysis Review

Baotou Dongbao Biotech Co. Ltd. (300239) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Baotou Dongbao Biotech Co. Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biotechnology
BioTech Capital Limited (BTC) - Financial and Strategic SWOT Analysis Review

BioTech Capital Limited (BTC) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of BioTech Capital Limited provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to ...

  • Industries : Biotechnology
Auricle Biomedical Corporation (AUB.P) - Strategic SWOT Analysis Review

Auricle Biomedical Corporation (AUB.P) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Auricle Biomedical Corporation provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clea ...

  • Industries : Biopharmaceutical
Animal Cloning Sciences, Inc. (ANML) - Strategic SWOT Analysis Review

Animal Cloning Sciences, Inc. (ANML) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Animal Cloning Sciences, Inc. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and ...

  • Industries : Biotechnology
Clal Biotechnology Industries Ltd. (CBI) - Financial and Strategic SWOT Analysis Review

Clal Biotechnology Industries Ltd. (CBI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Clal Biotechnology Industries Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biotechnology
Citurgia Biochemicals Ltd. (506373) - Financial and Strategic SWOT Analysis Review

Citurgia Biochemicals Ltd. (506373) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Citurgia Biochemicals Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biotechnology
Puma Biotechnology, Inc. (PBYI) - Financial and Strategic SWOT Analysis Review

Puma Biotechnology, Inc. (PBYI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2013
  • by Global Data

Summary This comprehensive SWOT profile of Puma Biotechnology, Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biotechnology
Biomarkers: Discovery Techniques and Applications - A Global Market Overview

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

  • $ 4 500
  • Industry report
  • November 2013
  • by Industry Experts

The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued in ...

  • Industries : Genomics
  • Countries : United States, World, Europe
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective

Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective

  • $ 2 495
  • Industry report
  • November 2013
  • by CHI Insight Pharma Reports

This report covers several technologies, epigenetic targets, and market outlook. The first part of this report covers necessary background information, mostly pertaining to epigenetic targets, and the ...

  • Industries : Biopharmaceutical
DNA Sequencing and PCR Markets

DNA Sequencing and PCR Markets

  • $ 3 400
  • Industry report
  • November 2013
  • by TriMark Publications

DNA sequencing and polymerase chain reaction (PCR) are two major technology platforms of value in life science research, drug discovery and clinical diagnostics. The markets for sequencing are extremely ...

  • Industries : Genomics
  • Countries : World
European Markets for Orthopedic Biomaterials - Executive Summary

European Markets for Orthopedic Biomaterials - Executive Summary

  • $ 295
  • Industry report
  • November 2013
  • by iData Research, Inc.

Summary for: The European orthopedic biomaterials market is expected to reach €376.7 million by 2019, with hyaluronic acid viscosupplementation as the largest segment. The European orthopedic biomaterials ...

  • Industries : Biomaterial
  • Countries : Europe
European Markets for Orthopedic Biomaterials

European Markets for Orthopedic Biomaterials

  • $ 8 995
  • Industry report
  • November 2013
  • by iData Research, Inc.

The European orthopedic biomaterials market is expected to reach €376.7 million by 2019, with hyaluronic acid viscosupplementation as the largest segment. The European orthopedic biomaterials market ...

  • Industries : Biomaterial
  • Countries : Europe
Commercialisation of Biosimilars: strategies for market penetration

Commercialisation of Biosimilars: strategies for market penetration

  • $ 495
  • Industry report
  • November 2013
  • by Firstword Pharma

Introduction Times, they are a-changin'—at least for the American biological product market. With five major biological products worth a collective US$35 billion in annual sales now facing imminent patent ...

  • Industries : Biopharmaceutical
  • Countries : United States
Physician Views: Oncologist reaction to Roche's Gazyva - US approval and new late-stage data versus Rituxan

Physician Views: Oncologist reaction to Roche's Gazyva - US approval and new late-stage data versus Rituxan

  • $ 645
  • Industry report
  • November 2013
  • by Firstword Pharma

Scope Roche's efforts to enhance its dominance of the haematological cancer market received notable momentum last week when the company gained FDA approval for Gazyva as a first-line treatment for chronic ...

  • Industries : Biological Therapy
  • Countries : United States
Global And China Industrial Enzyme Industry 2013 Market Research Report

Global And China Industrial Enzyme Industry 2013 Market Research Report

  • $ 2 200
  • Industry report
  • November 2013
  • by QY Research Group

Description The report firstly introduced Industrial Enzyme basic information included Industrial Enzyme definition classification application industry chain structure industry overview; international ...

  • Industries : Biopharmaceutical
  • Countries : China
Global Synthetic Biology Industry

Global Synthetic Biology Industry

  • $ 4 500
  • Industry report
  • November 2013
  • by Global Industry Analysts

This report analyzes the worldwide markets for Synthetic Biology in US$ Thousands by the following Application Areas: Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others. The report provides ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : World
Pharmaceutical Market: India A Comprehensive Industry Analysis Q3 2013

Pharmaceutical Market: India A Comprehensive Industry Analysis Q3 2013

  • $ 2 000
  • Industry report
  • November 2013
  • by Kelly Scientific Publications

“Pharmaceutical Market: India, A Competitive Industry Analysis Q3 2013” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its ...

  • Industries : Biopharmaceutical
  • Countries : India
Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2013

Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • October 2013
  • by Global Markets Direct

Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review ...

  • Industries : Biopharmaceutical
  • Countries : World
Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

  • $ 3 500
  • Industry report
  • October 2013
  • by GBI Research

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth Summary GBI Research has released the pharmaceutical report “Monoclonal ...

  • Industries : Biopharmaceutical
  • Countries : World
Competitor Analysis: CD19-Targeted Therapeutics

Competitor Analysis: CD19-Targeted Therapeutics

  • $ 264
  • Industry report
  • October 2013
  • by La Merie Publishing

Renewed interest in CD19 as target for antibody and T-cell Therapeutics The human CD19 antigen is a 95 kd transmembrane glycoprotein. It is specifically expressed in normal and neoplastic B cells, ...

  • Industries : Biological Therapy
GMO HOSTING & SECURITY, INC. (Symbol:3788) SWOT Analysis, Strategy, Revenues and Profits

GMO HOSTING & SECURITY, INC. (Symbol:3788) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genetically Modified Organism, Gmo
GMO Internet  Inc. (9449) - Financial and Strategic SWOT Analysis Review

GMO Internet Inc. (9449) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2013
  • by Global Data

Summary This comprehensive SWOT profile of GMO Internet Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring ...

  • Industries : Genetically Modified Organism, Gmo
SNP Genotyping and Analysis Market (GeneChips, Taqman Allelic Discrimination, Pyrosequencing, AB SNPlex, Sequenom MassARRAY MALDI-TOF) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

SNP Genotyping and Analysis Market (GeneChips, Taqman Allelic Discrimination, Pyrosequencing, AB SNPlex, Sequenom MassARRAY MALDI-TOF) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • October 2013
  • by Transparency Market Research

Single Nucleotide Polymorphism represents the most common type of mutation in genomes of all life forms. The study attempts to understand the various facets such as technology, applications and geographical ...

  • Industries : Genomics
  • Countries : World
The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry

The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry

  • $ 1 914
  • Industry report
  • October 2013
  • by La Merie Publishing

A comparative analysis and assessment of TCR technologies, pipelines and companies from an industry perspective Therapeutic monoclonal antibodies have become an increasingly successful treatment modality ...

  • Industries : Biopharmaceutical
  • Countries : United States
The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Markers)

The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Markers)

  • $ 3 995
  • Industry report
  • October 2013
  • by Kalorama Information

The effectiveness of biomarkers has made them essential to medicine, with successful products on the market and many products in development. This Kalorama Information report focuses on both the clinical ...

  • Industries : Genomics
  • Countries : World
Genetically Modified Crops in China

Genetically Modified Crops in China

  • $ 2 681
  • Industry report
  • October 2013
  • by CCM International Limited

China, with a plenty of field and great demand for crops, has the great potential in GM crops. Stimulated by the approval of safety certificates of GM rice and GM corn, two key grain crops in Asia, GM ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : China

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Primary Sources

United States

Merck KGaA

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.